To succeed, biotechs must leverage the competitive edge their unique
platform, novel modality, or deep expertise in a scientific pathway
offers. Biotechs put together an initial portfolio of drug discovery
projects (aka targets) to get started. However, they need to
periodically refine to improve their probability of success. Often
this means picking targets with lower risk, especially around their
biological validation. They also need to select protein targets that
align with their strategy and financing. The target selection must
also assess genetics, target history, 35 million publications,
genomics, clinical trials, and druggability. Although the biotech team
typically possesses expertise in the platform or the therapy area, it often lacks the ability to truly leverage its competitive edge.
At BioInfi we have 25+ years of pharmaceutical experience in strategic
advising, target selection, indication positioning, and drug repurposing. We help biotechs and pharma groups optimize their portfolio
to deliver much-needed medicines to patients. We also advise on selecting project likely to get the next round of funding or a pharma partnership by examining the competitive landscape and industry trends.
We offer a biomedical recruiting solution to find the best candidates
based on data analytics for any biomedical job opening. This includes
full-time scientific staff, C-Suite executives, advisors, consultants,
and board members. This is based on analyzing publications, citations,
clinical trials, author seniority, industrial experience, medical
school, and Medicare data to find the
true expert in any area. It is perhaps the best way to be DEI-compliant (Diversity, Equity, and Inclusion) as it is purely data-driven.
We partner with
and
.